{
    "title": "109_hr3423",
    "content": "The Act titled \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. It includes changes such as redesignating paragraphs, updating the fiscal year, and publishing fees in the Federal Register. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. It includes changes such as updating the fiscal year and publishing fees in the Federal Register. Additionally, it modifies premarket application fees for fiscal years 2006 and 2007. The Medical Device User Fee Stabilization Act of 2005 amends device user fees and fee setting procedures for fiscal years 2006 and 2007. It includes adjustments to premarket application fees, with fees based on a premarket application fee of $281,600 for fiscal year 2007. The Secretary may use unobligated carryover balances from previous fiscal years to ensure sufficient fee revenues for fiscal years 2006 and 2007. The Secretary may use unobligated carryover balances from previous fiscal years to ensure sufficient fee revenues for fiscal years 2006 and 2007, with notice required before funds are used. The Secretary must provide notice to Congress before using unobligated carryover balances for fee revenues in fiscal years 2006 and 2007, with specific committees to be informed. In subsection (d), the definition of \"small business\" is clarified as an entity with $30,000,000 or less in gross receipts or sales in its most recent tax return. The definition of \"small business\" is revised to include entities with $100,000,000 or less in gross receipts or sales in their most recent tax return. The definition of \"small business\" is revised to include entities with $100,000,000 or less in gross receipts or sales in their most recent tax return. Amendments include changes to subsections and clauses regarding financial thresholds. The definition of \"small business\" is revised to include entities with $100,000,000 or less in gross receipts or sales in their most recent tax return. Amendments include changes to subsections and clauses regarding financial thresholds, such as the Secretary meeting performance goals if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor. The definition of \"small business\" is revised to include entities with $100,000,000 or less in gross receipts or sales in their most recent tax return. Amendments include changes to financial thresholds, such as the Secretary meeting performance goals if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor for fiscal year 2005. For fiscal year 2005, if the appropriated amount is more than 1 percent less than the specified amount, certain conditions apply. For fiscal year 2005, the appropriated amount must be more than 1 percent less than the specified amount, with changes to the text regarding years. In subsection (h)(3), changes are made to subparagraphs (C), (D), and (E) for fiscal years 2006 and 2007. Additionally, \"subsection (c)(5)\" is replaced with \"subsection (c)(1)\" throughout the text. In subsection (h)(3), changes are made for fiscal years 2006 and 2007 by striking subparagraphs (D) and (E) and inserting necessary sums. Additionally, \"subsection (c)(5)\" is replaced with \"subsection (c)(1)\" throughout the text. Annual Reports under the Medical Device User Fee and Modernization Act of 2002 are also amended for fiscal years 2006 and 2007. The Modernization Act of 2002 is amended to include additional information for fiscal years 2006 and 2007, requiring reports to include details on different types of applications, fees paid, and businesses categorized by gross receipts. The report for fiscal years 2006 and 2007 must include details on various types of applications, fees paid, and businesses categorized by gross receipts in $10,000,000 intervals. The Secretary must certify that the FDA's salaries and expenses for functions related to devices, excluding device application reviews, meet or exceed the amounts for fiscal year 2002 adjusted by a factor. Additionally, Section 502(u) of the Federal Food, Drug, and Cosmetic Act addresses misbranded devices. Section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended to require reprocessed single-use devices to bear the manufacturer's name prominently. The Cosmetic Act is amended to require reprocessed single-use devices to prominently display the manufacturer's name or a recognized symbol. The Cosmetic Act is amended to require reprocessed single-use devices to prominently display the manufacturer's name, abbreviation, or symbol. If the original device does not have this information, a detachable label on the packaging can be used instead. Guidance from the Secretary of Health and Human Services is required within 180 days of the Act's enactment. The reprocessed device must display the manufacturer's information prominently, either on the device itself or through a detachable label on the packaging. The Secretary of Health and Human Services will provide guidance on what constitutes \"prominent and conspicuous\" within 180 days of the Act's enactment. The FDA will issue guidance on when manufacturer information is not considered \"prominent and conspicuous\" on medical devices, as required by the Federal Food, Drug, and Cosmetic Act. The effective date for this guidance will be specified in an amendment to the Medical Device User Fee and Modernization Act of 2002. The effective date for guidance on manufacturer information on medical devices will be specified in an amendment to the Federal Food, Drug, and Cosmetic Act. The effective date for guidance on manufacturer information on medical devices will be 12 months after the date of enactment of the Medical Device User Fee Stabilization Act of 2005, or when the original device is labeled with the manufacturer's name, abbreviation, or symbol, whichever is later. The effective date for guidance on manufacturer information on medical devices will be 12 months after the date of enactment of the Medical Device User Fee Stabilization Act of 2005. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}